{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:05:05Z","timestamp":1789844705956,"version":"4.0.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Alcon Services AG, Taiwan Branch","award":["Investigator-Initiated Trial # 60298913"],"award-info":[{"award-number":["Investigator-Initiated Trial # 60298913"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s40123-024-01015-9","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T18:02:18Z","timestamp":1723312938000},"page":"2615-2627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of Two Artificial Tears Containing Hyaluronic Acid for Post Cataract Surgery Dry Eye Disease: A Randomized Controlled Trial"],"prefix":"10.1007","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct06221345","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9466-6986","authenticated-orcid":false,"given":"Chi-Chin","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hsi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Ni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,10]]},"reference":[{"issue":"4","key":"1015_CR1","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1007\/s12325-020-01288-z","volume":"37","author":"P Fogagnolo","year":"2020","unstructured":"Fogagnolo P, Favuzza E, Marchina D, et al. New therapeutic strategy and innovative lubricating ophthalmic solution in minimizing dry eye disease associated with cataract surgery: a randomized, prospective study. Adv Ther. 2020;37(4):1664\u201374. https:\/\/doi.org\/10.1007\/s12325-020-01288-z.","journal-title":"Adv Ther."},{"key":"1015_CR2","unstructured":"National Institute for Health and Care Excellence: Guidelines. Cataracts in adults: management. National Institute for Health and Care Excellence (NICE). 2017."},{"key":"1015_CR3","unstructured":"Moshirfar M, Milner D, Patel BC. Cataract Surgery. StatPearls. StatPearls Publishing, StatPearls Publishing LLC.; 2023."},{"issue":"1","key":"1015_CR4","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1186\/s12889-022-14491-0","volume":"22","author":"R Fang","year":"2022","unstructured":"Fang R, Yu YF, Li EJ, et al. Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019. BMC Public Health. 2022;22(1):2068. https:\/\/doi.org\/10.1186\/s12889-022-14491-0.","journal-title":"BMC Public Health."},{"issue":"8","key":"1015_CR5","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jcrs.2014.12.056","volume":"41","author":"R Mencucci","year":"2015","unstructured":"Mencucci R, Boccalini C, Caputo R, Favuzza E. Effect of a hyaluronic acid and\u00a0carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. J Cataract Refract Surg. 2015;41(8):1699\u2013704. https:\/\/doi.org\/10.1016\/j.jcrs.2014.12.056.","journal-title":"J Cataract Refract Surg."},{"issue":"1","key":"1015_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/ICU.0000000000000227","volume":"27","author":"C Sutu","year":"2016","unstructured":"Sutu C, Fukuoka H, Afshari NA. Mechanisms and management of dry eye in cataract surgery patients. Curr Opin Ophthalmol. 2016;27(1):24\u201330. https:\/\/doi.org\/10.1097\/ICU.0000000000000227.","journal-title":"Curr Opin Ophthalmol"},{"issue":"8","key":"1015_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jcrs.2014.12.056","volume":"41","author":"R Mencucci","year":"2015","unstructured":"Mencucci R, Boccalini C, Caputo R, Favuzza E. Effect of a hyaluronic acid and carboxymethylcellulose ophthalmic solution on ocular comfort and tear-film instability after cataract surgery. J Cataract Refract Surg. 2015;41(8):1699\u2013704. https:\/\/doi.org\/10.1016\/j.jcrs.2014.12.056.","journal-title":"J Cataract Refract Surg"},{"key":"1015_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12886-015-0058-3","volume":"15","author":"S Cetinkaya","year":"2015","unstructured":"Cetinkaya S, Mestan E, Acir NO, Cetinkaya YF, Dadaci Z, Yener HI. The course of dry eye after phacoemulsification surgery. BMC Ophthalmol. 2015;15:68. https:\/\/doi.org\/10.1186\/s12886-015-0058-3.","journal-title":"BMC Ophthalmol."},{"issue":"3","key":"1015_CR9","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575\u2013628. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.006.","journal-title":"Ocul Surf"},{"key":"1015_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020207","author":"P Agarwal","year":"2021","unstructured":"Agarwal P, Craig JP, Rupenthal ID. Formulation considerations for the management of dry eye disease. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13020207.","journal-title":"Pharmaceutics."},{"key":"1015_CR11","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.2147\/opth.S177176","volume":"12","author":"M Labetoulle","year":"2018","unstructured":"Labetoulle M, Schmickler S, Galarreta D, et al. Efficacy and safety of dual-polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study. Clin Ophthalmol. 2018;12:2499\u2013508. https:\/\/doi.org\/10.2147\/opth.S177176.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1015_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1089\/jop.2010.0025","volume":"26","author":"WF Davitt","year":"2010","unstructured":"Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347\u201353. https:\/\/doi.org\/10.1089\/jop.2010.0025.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"1015_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.8.6.2","volume":"8","author":"P Aragona","year":"2019","unstructured":"Aragona P, Simmons PA, Wang H, Wang T. Physicochemical properties of hyaluronic acid-based lubricant eye drops. Transl Vis Sci Technol. 2019;8(6):2. https:\/\/doi.org\/10.1167\/tvst.8.6.2.","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"1015_CR14","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1167\/iovs.06-0848","volume":"48","author":"Q Garrett","year":"2007","unstructured":"Garrett Q, Simmons PA, Xu S, et al. Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2007;48(4):1559\u201367. https:\/\/doi.org\/10.1167\/iovs.06-0848.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1015_CR15","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.2147\/opth.S259704","volume":"14","author":"E Favuzza","year":"2020","unstructured":"Favuzza E, Cennamo M, Vicchio L, Giansanti F, Mencucci R. Protecting the ocular surface in cataract surgery: the efficacy of the perioperative use of a hydroxypropyl guar and hyaluronic acid ophthalmic solution. Clin Ophthalmol. 2020;14:1769\u201375. https:\/\/doi.org\/10.2147\/opth.S259704.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"1015_CR16","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp MA. Report of the National Eye Institute\/industry workshop on clinical trials in dry eyes. Clao j. 1995;21(4):221\u201332.","journal-title":"Clao j"},{"issue":"6","key":"1015_CR17","doi-asserted-by":"publisher","first-page":"BIO168","DOI":"10.1167\/iovs.17-21831","volume":"58","author":"F Amparo","year":"2017","unstructured":"Amparo F, Wang H, Yin J, Marmalidou A, Dana R. Evaluating corneal fluorescein staining using a novel automated method. Investig Ophthalmol Visual Sci. 2017;58(6):BIO168\u201373. https:\/\/doi.org\/10.1167\/iovs.17-21831.","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"5","key":"1015_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615\u201321. https:\/\/doi.org\/10.1001\/archopht.118.5.615.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1015_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archophthalmol.2009.356","volume":"128","author":"KL Miller","year":"2010","unstructured":"Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128(1):94\u2013101. https:\/\/doi.org\/10.1001\/archophthalmol.2009.356.","journal-title":"Arch Ophthalmol"},{"key":"1015_CR20","doi-asserted-by":"publisher","unstructured":"Chan YH, Sun CC. Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen. Taiwan J Ophthalmol. 2023;13(1):68\u201374. https:\/\/doi.org\/10.4103\/tjo.TJO-D-22-00140","DOI":"10.4103\/tjo.TJO-D-22-00140"},{"key":"1015_CR21","unstructured":"Brott NR, Ronquillo Y. Schirmer Test. StatPearls. StatPearls Publishing"},{"key":"1015_CR22","unstructured":"Copyright \u00a9 2023, StatPearls Publishing LLC.; 2023."},{"key":"1015_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.exer.2013.08.010","volume":"117","author":"DF Sweeney","year":"2013","unstructured":"Sweeney DF, Millar TJ, Raju SR. Tear film stability: a review. Exp Eye Res. 2013;117:28\u201338. https:\/\/doi.org\/10.1016\/j.exer.2013.08.010.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1015_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.20471\/acc.2019.58.01.09","volume":"58","author":"S Vidas Pauk","year":"2019","unstructured":"Vidas Pauk S, Petri\u010dek I, Juki\u0107 T, et al. Noninvasive tear film break-up time assessment using handheld lipid layer examination instrument. Acta Clin Croat. 2019;58(1):63\u201371. https:\/\/doi.org\/10.20471\/acc.2019.58.01.09.","journal-title":"Acta Clin Croat"},{"issue":"1","key":"1015_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00003226-199801000-00007","volume":"17","author":"SC Pflugfelder","year":"1998","unstructured":"Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998;17(1):38\u201356. https:\/\/doi.org\/10.1097\/00003226-199801000-00007.","journal-title":"Cornea"},{"issue":"3","key":"1015_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/tjo.tjo_59_19","volume":"9","author":"YC Tai","year":"2019","unstructured":"Tai YC, Sun CC. Effects of flap diameter on dry eye parameters and corneal sensation after femtosecond laser-assisted LASIK. Taiwan J Ophthalmol Jul-Sep. 2019;9(3):166\u201372. https:\/\/doi.org\/10.4103\/tjo.tjo_59_19.","journal-title":"Taiwan J Ophthalmol Jul-Sep"},{"issue":"5","key":"1015_CR27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.ajo.2015.08.005","volume":"160","author":"EZ Rahman","year":"2015","unstructured":"Rahman EZ, Lam PK, Chu CK, Moore Q, Pflugfelder SC. Corneal sensitivity in tear dysfunction and its correlation with clinical parameters and blink rate. Am J Ophthalmol. 2015;160(5):858-866.e5. https:\/\/doi.org\/10.1016\/j.ajo.2015.08.005.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1015_CR28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1177\/1120672120929958","volume":"30","author":"K Naderi","year":"2020","unstructured":"Naderi K, Gormley J, O\u2019Brart D. Cataract surgery and dry eye disease: a review. Eur J Ophthalmol. 2020;30(5):840\u201355. https:\/\/doi.org\/10.1177\/1120672120929958.","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"1015_CR29","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s40123-022-00513-y","volume":"11","author":"M Miura","year":"2022","unstructured":"Miura M, Inomata T, Nakamura M, et al. Prevalence and characteristics of dry eye disease after cataract surgery: a systematic review and meta-analysis. Ophthalmol Ther. 2022;11(4):1309\u201332. https:\/\/doi.org\/10.1007\/s40123-022-00513-y.","journal-title":"Ophthalmol Ther"},{"key":"1015_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.980714","volume":"9","author":"LY Pan","year":"2022","unstructured":"Pan LY, Kuo YK, Chen TH, Sun CC. Dry eye disease in patients with type II diabetes mellitus: a retrospective, population-based cohort study in Taiwan. Front Med (Lausanne). 2022;9: 980714. https:\/\/doi.org\/10.3389\/fmed.2022.980714.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"1015_CR31","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/aos.15159","volume":"100","author":"L Hynnekleiv","year":"2022","unstructured":"Hynnekleiv L, Magno M, Vernhardsdottir RR, et al. Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol. 2022;100(8):844\u201360. https:\/\/doi.org\/10.1111\/aos.15159.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"1015_CR32","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1089\/jop.2017.0080","volume":"34","author":"E Carlson","year":"2018","unstructured":"Carlson E, Kao WWY, Ogundele A. Impact of hyaluronic acid-containing artificial tear products on reepithelialization in an in vivo corneal wound model. J Ocul Pharmacol Ther. 2018;34(4):360\u20134. https:\/\/doi.org\/10.1089\/jop.2017.0080.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"1015_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1076\/ceyr.28.1.55.23495","volume":"28","author":"MT Christensen","year":"2004","unstructured":"Christensen MT, Cohen S, Rinehart J, et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr Eye Res. 2004;28(1):55\u201362. https:\/\/doi.org\/10.1076\/ceyr.28.1.55.23495.","journal-title":"Curr Eye Res"},{"issue":"4","key":"1015_CR34","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1167\/iovs.06-0848","volume":"48","author":"Q Garrett","year":"2007","unstructured":"Garrett Q, Simmons PA, Xu S, et al. Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing. Invest Ophthalmol Vis Sci. 2007;48(4):1559\u201367. https:\/\/doi.org\/10.1167\/iovs.06-0848.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"1015_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/jop.2014.0164","volume":"31","author":"R Rangarajan","year":"2015","unstructured":"Rangarajan R, Kraybill B, Ogundele A, Ketelson HA. Effects of a hyaluronic acid\/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium. J Ocul Pharmacol Ther. 2015;31(8):491\u20137. https:\/\/doi.org\/10.1089\/jop.2014.0164.","journal-title":"J Ocul Pharmacol Ther"},{"key":"1015_CR36","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2147\/opth.S163744","volume":"12","author":"A Wallerstein","year":"2018","unstructured":"Wallerstein A, Jackson WB, Chambers J, Moezzi AM, Lin H, Simmons PA. Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose. Clin Ophthalmol. 2018;12:839\u201348. https:\/\/doi.org\/10.2147\/opth.S163744.","journal-title":"Clin Ophthalmol"},{"key":"1015_CR37","doi-asserted-by":"publisher","unstructured":"Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocular Surface. 2017\/07\/01\/ 2017;15(3):539\u2013574. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001","DOI":"10.1016\/j.jtos.2017.05.001"},{"key":"1015_CR38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/opth.S78184","volume":"9","author":"PA Simmons","year":"2015","unstructured":"Simmons PA, Liu H, Carlisle-Wilcox C, Vehige JG. Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial. Clin Ophthalmol. 2015;9:665\u201375. https:\/\/doi.org\/10.2147\/opth.S78184.","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"1015_CR39","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1177\/1120672119896427","volume":"30","author":"MG Zamora","year":"2020","unstructured":"Zamora MG, Caballero EF, Maldonado MJ. Short-term changes in ocular surface signs and symptoms after phacoemulsification. Eur J Ophthalmol. 2020;30(6):1301\u20137. https:\/\/doi.org\/10.1177\/1120672119896427.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"1015_CR40","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10792-018-0828-z","volume":"39","author":"W Xue","year":"2019","unstructured":"Xue W, Zhu MM, Zhu BJ, et al. Long-term impact of dry eye symptoms on vision-related quality of life after phacoemulsification surgery. Int Ophthalmol. 2019;39(2):419\u201329. https:\/\/doi.org\/10.1007\/s10792-018-0828-z.","journal-title":"Int Ophthalmol"},{"issue":"7","key":"1015_CR41","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/s0008-4182(04)80071-1","volume":"39","author":"FA Adatia","year":"2004","unstructured":"Adatia FA, Michaeli-Cohen A, Naor J, Caffery B, Bookman A, Slomovic A. Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sj\u00f6gren\u2019s syndrome. Can J Ophthalmol. 2004;39(7):767\u201371. https:\/\/doi.org\/10.1016\/s0008-4182(04)80071-1.","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"1015_CR42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3928\/1542-8877-19970101-07","volume":"28","author":"I J\u00fcrgens","year":"1997","unstructured":"J\u00fcrgens I, Matheu A, Castilla M. Ocular hypertension after cataract surgery: a comparison of three surgical techniques and two viscoelastics. Ophthalmic Surg Lasers. 1997;28(1):30\u20136.","journal-title":"Ophthalmic Surg Lasers"},{"key":"1015_CR43","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.2147\/opth.S428725","volume":"17","author":"S Srinivasan","year":"2023","unstructured":"Srinivasan S, Garofalo R, Williams R. Safe and effective management of dry eye symptoms with hydroxypropyl guar and hyaluronic acid dual-polymer lubricating eye drops: a review of preclinical and clinical studies. Clin Ophthalmol. 2023;17:3883\u201398. https:\/\/doi.org\/10.2147\/opth.S428725.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"1015_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12886-021-02129-5","volume":"21","author":"J Kim","year":"2021","unstructured":"Kim J, Kim MK, Ha Y, Paik HJ, Kim DH. Improved accuracy of intraocular lens power calculation by preoperative management of dry eye disease. BMC Ophthalmol. 2021;21(1):364. https:\/\/doi.org\/10.1186\/s12886-021-02129-5.","journal-title":"BMC Ophthalmol."},{"key":"1015_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2020.03.044","volume":"216","author":"R Dana","year":"2020","unstructured":"Dana R, Meunier J, Markowitz JT, Joseph C, Siffel C. Patient-reported burden of dry eye disease in the United States: results of an online cross-sectional survey. Am J Ophthalmol. 2020;216:7\u201317. https:\/\/doi.org\/10.1016\/j.ajo.2020.03.044.","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"1015_CR46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12325-010-0052-3","volume":"27","author":"CL Springs","year":"2010","unstructured":"Springs CL. Novel hydroxypropyl-guar gellable lubricant eye drops for treatment of dry eye. Adv Ther. 2010;27(10):681\u201390. https:\/\/doi.org\/10.1007\/s12325-010-0052-3.","journal-title":"Adv Ther"},{"key":"1015_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18052383","author":"YJ Yang","year":"2021","unstructured":"Yang YJ, Lee WY, Kim YJ, Hong YP. A meta-analysis of the efficacy of hyaluronic acid eye drops for the treatment of dry eye syndrome. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18052383.","journal-title":"Int J Environ Res Public Health."},{"issue":"10","key":"1015_CR48","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/eye.2017.73","volume":"31","author":"M Labetoulle","year":"2017","unstructured":"Labetoulle M, Chiambaretta F, Shirlaw A, Leaback R, Baudouin C. Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye. Eye (Lond). 2017;31(10):1409\u201316. https:\/\/doi.org\/10.1038\/eye.2017.73.","journal-title":"Eye (Lond)"},{"issue":"4","key":"1015_CR49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/bjophthalmol-2016-308608","volume":"101","author":"M Labetoulle","year":"2017","unstructured":"Labetoulle M, Messmer EM, Pisella PJ, Ogundele A, Baudouin C. Safety and efficacy of a hydroxypropyl guar\/polyethylene glycol\/propylene glycol-based lubricant eye-drop in patients with dry eye. Br J Ophthalmol. 2017;101(4):487\u201392. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308608.","journal-title":"Br J Ophthalmol"},{"issue":"14","key":"1015_CR50","first-page":"3834","volume":"52","author":"M Guillon","year":"2011","unstructured":"Guillon M, Maissa CA, Wong S, Griffin JM, Christensen MT. Functional visual performance of Systane ultra after 4 weeks of use. Invest Ophthalmol Vis Sci. 2011;52(14):3834\u20133834.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01015-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-01015-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01015-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T14:50:58Z","timestamp":1726671058000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-01015-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-01015-9","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,10]]},"assertion":[{"value":"24 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Chi-Chin Sun, Yuan-Hsi Chan, Pei-Wei Huang, and Nan-Ni Chen confirm that they have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the Chang Gung Medical Foundation (IRB No.: 202002539A3) prior to any study procedures. The research team members adhered to the tenets of the Declaration of Helsinki throughout the study. Informed consent was obtained from all participants involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}